(Q34177249)

English

Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

0 references

vitamin B12 deficiency

0 references

vitamin D deficiency

0 references

chronic hepatitis

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Pierluigi Toniutto

12

object named as

Pierluigi Toniutto

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

3

object named as

Carlo Fabris

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Davide Bitetto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Giovanna Fattovich

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Elisa Ceriani

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Edmondo Falleti

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ezio Fornasiere

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Michela Pasino

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Donatella Ieluzzi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Annarosa Cussigh

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Sara Cmet

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

0 references

publication date

1 April 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

53

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1118-1126

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480318%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

The global burden of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Treatment predictors of a sustained virologic response in hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Associations between serum lipids and hepatitis C antiviral treatment efficacy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Prevalence of vitamin D deficiency in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Vitamin D and the intracrinology of innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Vitamin D: modulator of the immune system.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Predictors of response to therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Human macrophage host defense against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Vitamin D signaling, infectious diseases, and regulation of innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24201

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34177249&oldid=1980481038"